Rachel H Clare

7PUBLICATIONS
37CO-AUTHORS
Microbial ecologyBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsMedical parasitologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2024
Targeting a microbiota Wolbachian aminoacyl-tRNA synthetase to block its pathogenic host.

Guillaume Hoffmann, Maria Lukarska, Rachel H Clare

|Sep 16, 2021
Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis.

Paul McGillan, Neil G Berry, Gemma L Nixon

|Apr 09, 2019
Development of a High-Throughput Cytometric Screen to Identify Anti- Wolbachia Compounds: The Power of Public-Private Partnership.

Rachel H Clare, Roger Clark, Catherine Bardelle

|Mar 15, 2019
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.

Mark J Taylor, Thomas W von Geldern, Louise Ford

|Jan 09, 2019
AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis.

W David Hong, Farid Benayoud, Gemma L Nixon

|Jan 04, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides.

Rachel H Clare, Catherine Bardelle, Paul Harper

Pageof 2